Pharma Pressreleases

Keep up to date with the latest technological developments happening across the Pharmaceutical industry. Our press releases can help you boost your online reach and exposure worldwide. Our Press releases provides information on the latest research in pharma.

GC Pharma to Establish Curevo a Seattlebased New Company Dedicated to Development of New Vaccines

Monday, May 21, 2018

GC Pharma formerly known as Green Cross Corporation KRX 006280 a South Korean biopharmaceutical company today announced the establishment of Curevo Inc Curevo The newly established Seattlebased company39s goal is to support GC Pharma39s vaccine development activities GC Pharma builds a strategic ..

Fibrocell Reports on Interim Results and Progress of Phase 12 Clinical Trial of FCX007 Gene Therapy for Recessive Dystrophic Epidermolysis Bullosa

Monday, May 21, 2018
GLOBE NEWSWIRE

FCX007 welltolerated up to 52 weeks postadministration Continued positive trends noted in wound healing and pharmacology signals including type VII collagen expression and evidence of anchoring fibrils Company to Host Conference Call Webcast Today at 830 am EDT EXTON Pa May 21 2018 GLOB..

Innovest Global Inc Call Center Wins 650000 Exclusive Contract with Fortune 500 Company

Monday, May 21, 2018
GLOBE NEWSWIRE

CLEVELAND May 21 2018 GLOBE NEWSWIRE Innovest Global Inc OTC PINKIVST Call Center has won a 650000 contract as the exclusive provider for an industry leading medical supply division of a Fortune 500 company with over 2 billion in annual revenue The contract provides for the service to exceed 1mm..

NuvusGro NUVG Introduces the Nuvus Mobile Mining Unit MoMu Utilizing its GrowDroid Enterprise Technology MoMu to Mine Bitcoin Ether BCH and Altcoins

Monday, May 21, 2018
GLOBE NEWSWIRE

Saint Petersburg FL May 21 2018 GLOBE NEWSWIRE NuvusGro Corp OTC PINK NUVG a provider of advanced Controlled Environment Agriculture CEA with sophisticated automation and analytical tools for the cultivators of legal industrial hemp and marijuana announces today that NuvusGro has been contr..

Attis Industries Nearing Completion of its First Federal Laboratory

Monday, May 21, 2018
GLOBE NEWSWIRE

Expects to Begin Processing New Blood and Toxicology Samples in June Exploring Additional Lab Opportunities in Florida Georgia Texas Pennsylvania California and the Northwest US MILTON GA May 21 2018 GLOBE NEWSWIRE Attis Industries Inc NASDAQ ATIS the Company or Attis an integrated..

Edwards Announces Key Events For EuroPCR 2018

Monday, May 21, 2018
PR Newswire

PARIS May 21 2018 PRNewswire Edwards Lifesciences Corporation NYSE EW the global leader in patientfocused innovations for structural heart disease and critical care monitoring today announced key events for the company during EuroPCR 2018 the annual meeting of the European Association of Percutan..

Resistance ecofriendly and big data The future of agrarian matters

Monday, May 21, 2018
PR Newswire

Cuttingedge technologies and equipment found at Asia AgriTech Expo from July 2628 TAIPEI Taiwan May 21 2018 PRNewswire Crosscutting business model can now be seen in the fields of agriculture aquaculture and livestock The Asia AgriTech Expo and Forum is a comprehensive expression of it Focusin..

Sobi Emphasises Commitment to Haemophilia Community at WFH 2018 World Congress

Monday, May 21, 2018
PR Newswire

STOCKHOLM May 21 2018 PRNewswire Recent data show qualityoflife improvements for patients treated prophylactically with Elocta and Alprolix extended halflife haemophilia therapies Swedish Orphan Biovitrum AB publ Sobi STOSOBI will present data at the World Federation of Hemophilia WFH 2018 World..

NeuroVive and Yungjin Reports Positive KL1333 Phase I Clinical Study Results Paving the way for Further Clinical Development

Monday, May 21, 2018
PR Newswire

LUND Sweden and SEOUL South Korea May 21 2018 PRNewswire NeuroVive Pharmaceutical ABNasdaq Stockholm NVP OTCQX NEVPF and Yungjin Pharm Corporation Ltd South Korea Stock Market KRX 003520 today jointly announced positive topline results after data base lock in the phase I single ascending dose SAD..

Caris Life Sciences to Present New Molecular Findings at the 2018 ASCO Annual Meeting

Monday, May 21, 2018
PR Newswire

IRVING Texas May 21 2018 PRNewswire Caris Life Sciences a leading innovator in molecular science focused on fulfilling the promise of precision medicine today announced the acceptance of 10 abstracts including one oral presentation by the American Society of Clinical Oncology ASCO for presentation..

HealthScripts Ambassador Program Available to PAs and NPs

Monday, May 21, 2018
PR Newswire

CARY NC May 21 2018 PRNewswire Today HealthScripts the nations leading Advanced Practice Provider Network announced a nationwide educational initiative that provides clinical sharing opportunities for Advanced Practice Providers In partnership with the worlds le..

Lannett Receives FDA Approval For Dronabinol Capsules

Monday, May 21, 2018
PR Newswire

PHILADELPHIA May 21 2018 PRNewswire Lannett Company Inc NYSE LCI today announced that it received approval from the US Food and Drug Administration FDA of its Abbreviated New Drug Application ANDA for Dronabinol Capsules USP 25 mg 5 mg and 10 mg the therapeutic equivalent to the reference listed d..

Ascentage Pharma Announces Promising Phase 1 Interim Results in Two Clinical Programs to Be Presented at 2018 ASCO Annual Meeting

Monday, May 21, 2018
PR Newswire

ROCKVILLE Md and HONG KONG May 21 2018 PRNewswireAscentage Pharma a global clinicalstage biopharmaceutical company dedicated to developing apoptosistargeted therapies for cancers and other diseases today announced that interim results from two clinical programs will be presented at the 2018 Americ..

Realm Therapeutics Presents Data Highlighting its Proprietary Immunomodulatory Technologys Potential in Acne and Psoriasis at IID 2018

Monday, May 21, 2018
PR Newswire

MALVERN Pa May 21 2018 PRNewswire Realm Therapeutics plc AIM RLM a clinical stage biopharmaceutical company focused on developing novel therapeutics in immunemediated diseases today announces that the Company presented a poster at the 2018 International Investigative Dermatology IID Meeting in..

MaxCyte Reports Preclinical Results at ASGCT Annual Meeting Showing Efficient Correction of Sickle Cell Mutation in Hematopoietic Stem Cells HSC

Monday, May 21, 2018
PR Newswire

GAITHERSBURG Md May 21 2018 PRNewswire MaxCyte the global cellbased medicines and life sciences company today announced that Linghong Li PhD Director Cell Engineering presented preclinical data at the annual meeting of the American Society of Gene and Cell Therapy ASGCT in Chicago on Friday May 1..

Verge Genomics Announces Landmark Effort to Generate Fields First Single Cell Data from Patients with Parkinsons Disease

Monday, May 21, 2018
PR Newswire

SAN FRANCISCO May 21 2018 PRNewswire Verge Genomics a drug discovery company utilizing machine learning to develop new therapeutics announced today the launch of a groundbreaking initiative to sequence genes expressed in the brains of Parkinsons patients at a single cell resolution generating the..

Alkahest Receives Grant from Michael J Fox Foundation Funding Will Support Preclinical Evaluation of ALK4290 for Parkinsons Disease

Monday, May 21, 2018
PR Newswire

SAN CARLOS Calif May 21 2018 PRNewswire Alkahest Inc Alkahest a clinicalstage biotechnology company focused on developing innovative therapies to treat agerelated diseases today announced that it has been awarded a grant from The Michael J Fox Foundation for Parkinsons Research MJFF entitled Devel..

Nox Medical Achieves Success in Patent Infringement Lawsuit

Monday, May 21, 2018
PR Newswire

REYKJAVIK Iceland May 21 2018 PRNewswire Nox Medical a leading sleep diagnostic medical device company and innovator has achieved a major success in its case in the US District Court for the District of Delaware alleging that Natus Neurology willfully infringed Nox Medicals US Patent No 9059532 ..

Harmony Biosciences Receives Breakthrough Therapy And Fast Track Designations For Pitolisant

Monday, May 21, 2018
PR Newswire

PLYMOUTH MEETING Pa May 21 2018 PRNewswire Harmony Biosciences LLC Harmony today announced that it has received Breakthrough Therapy and Fast Track designations for its investigational product pitolisant from the US Food and Drug Administration FDA Breakthrough Therapy designation has been granted..

Zavante Therapeutics To Present Fosfomycin For Injection Data At ASM Microbe 2018 Meeting

Monday, May 21, 2018
PR Newswire

SAN DIEGO May 21 2018 PRNewswire Zavante Therapeutics Inc a biopharmaceutical company focused on developing novel therapies to improve the outcomes of hospitalized patients todayannounced that the company and its research collaborators will present seven posters related to Zavantes investigational..

TOP